|
WO2009120304A1
|
|
Thrombin derived peptides for smooth muscle relaxation
|
|
AU2009229402A1
|
|
Method of treating peripheral arterial disease
|
|
WO2008100567A2
|
|
Thrombin peptide derivatives for treating fractures in osteopenic patients
|
|
CA2663547A1
|
|
Method of treating endothelial dysfunction
|
|
EP1559431A1
|
|
Pharmaceutical composition for thrombin peptide derivatives
|
|
AU2003256343A1
|
|
Thrombin peptide derivatives
|
|
AU2003247848A1
|
|
Thrombin peptide derivative dimers
|
|
EP1414487A2
|
|
Use of thrombin-derived peptides for the therapy of chronic dermal ulcers
|
|
TWI257307B
|
|
Pharmaceutical composition for cardiac tissue repair
|
|
AU3907901A
|
|
Combination pro/supination and flexion therapeutic mobilization device
|
|
WO0168027A2
|
|
Control device for the therapeutic mobilization of joints
|
|
CN1694670A
|
|
Combination pro/supination and flexion therapeutic mobilization device
|
|
CA2216863A1
|
|
Continuous passive motion device for upper extremity forearm therapy
|
|
US5951499A
|
|
Continuous passive motion device for upper extremity forearm therapy
|
|
US5879301A
|
|
Ultrasonic bone assessment method and apparatus
|
|
CA2235465A1
|
|
Active/passive device for rehabilitation of upper and lower extremities
|
|
US5860941A
|
|
Active/passive device for rehabilitation of upper and lower extremities
|
|
US5792040A
|
|
Patient interface device for generating therapeutic magnetic fields
|
|
US5651363A
|
|
Ultrasonic bone assessment method and apparatus
|
|
US5738636A
|
|
Continuous passive motion devices for joints
|
